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The importance of tissue microarrays (TMA) as clinical validation tools for cDNA microarray results is
increasing, whereas researchers are still suffering from TMA data management issues. After we developed
a comprehensive data model for TMA data storage, exchange and analysis, TMA-OM, we focused our
attention on the development of a user-friendly exchange format with high expressivity in order to pro-
mote data communication of TMA results and TMA-OM supportive database applications. We developed
TMA-TAB, a spreadsheet-based data format for TMA data submission to the TMA-OM supportive TMA
database system. TMA-TAB was developed by simplifying, modifying and reorganizing classes, attributes
and templates of TMA-OM into ﬁve entities: experiment, block, slide, core_in_block, and core_in_slide.
Five tab-delimited formats (investigation design format, block description format, slide description for-
mat, core clinicohistopathological data format, and core result data format) were made, each representing
the entities of experiment, block, slide, core_in_block, and core_in_slide. We implemented TMA-TAB
import and export modules on Xperanto-TMA, a TMA-OM supportive database application, to facilitate
data submission. Development and implementation of TMA-TAB and TMA-OM provide a strong infra-
structure for powerful and user-friendly TMA data management.
 2009 Elsevier Inc. All rights reserved.1. Introduction
Tissue microarrays (TMA) are a promising array-based technol-
ogy in cancer research and their importance in pathology is
increasing due to their role in the clinical validation of cDNA
microarrays [1]. TMA technology allows researchers to examine
the expression of protein, DNA or RNA on hundreds or thousands
of tissue samples while preserving morphology [2]. This increased
throughput accelerates the discovery of important biologic mark-
ers compared to traditional marker studies using whole slide sec-
tions and has made this technology an essential tool in human
protein proﬁling [3].
There is an enormous amount of data, including clinical and his-
topathological information associatedwith the cores in TMA blocks.
This data grows exponentially even with a single experiment,
which generates interpretation results for each core on a slide.ll rights reserved.
omedical Informatics, Seoul
ong Chongno-gu, Seoul 110-Without powerful data management tools, the incredible volume
of TMA data can be a burden to researchers, resulting in improper
interpretation of data. For example, if data about the interpretation
of the cores is recorded in one repository and data about the clinical
and histopathological ﬁndings in another and there is no available
informatics tool to integrate these data, onemay try to do this man-
ually, increasing chances of misinterpretation, especially without
proper identiﬁer and vocabulary management. Many TMA
researchers typically work in laboratories without bioinformatics
support and have difﬁculties managing TMA data.
In biomedical research, the development of standards, such as
minimum information speciﬁcation, data exchange format, and ob-
ject model are essential to provide a solid basis for the develop-
ment of data management applications. In the ﬁelds of cDNA
microarray and proteomics, these efforts have been made by the
Microarray Gene Expression Data (MGED) group and the Human
Proteome Organization (HUPO), respectively (Table 1) [4–8]. These
standards are successfully implemented and widely used, the typ-
ical examples being ArrayExpress in cDNA microarray and PEDRo
in proteomics. Along with these trends, standards have also been
proposed for TMAs.
Table 1
Comparison between development of data standards in biomedical research.
Data standards cDNA microarray data Proteomics data TMA data
Minimum information speciﬁcation MIAME MAIPE TMA DES
Data model MAGE-OM PSI-OM TMA-OM
XML format for data exchange MAGE-ML PSI-ML TMA DES
Spreadsheet format for data exchange MAGE-TAB PRIDE proteomics harvest spreadsheet Not available
Implementation ArrayExpress PEDRo Xperanto-TMA
MIAME: minimal information about microarray experiment, MAGE-OM: microarray gene expression object model, MAGE-ML: microarray gene expression markup language,
MAGE-TAB: microarray gene expression tabular, MAIPE: minimum information about a proteomics experiment, PSI-OM: proteomics standards initiative object model, PSI-
ML: proteomics standards initiative markup language, PRIDE: proteomics identiﬁcations database, PEDRo: proteome experimental data repository, TMA DES: tissue
microarray data exchange speciﬁcation, TMA-OM: tissue microarray-object model.
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cess TMA data exchange speciﬁcation (TMA DES) as a format for
sharing TMA data in 2003 [9]. TMA DES is a well-made XML docu-
ment with a suitable structure that contains essential data ele-
ments of TMAs, such as experiment, block, slide and core in a
hierarchical design and is very useful in the management of TMA
data.
Our group proposed TMA-OM as a data model with integrity,
ﬂexibility and extensibility in dealing with TMA data [10]. TMA-
OM provides a comprehensive model for storage, analysis and ex-
change of TMA data and also facilitates model-level integration
with other biological models. During the development of TMA-
OM, every kind of data and event that a TMA experiment can pro-
duce was thoroughly analyzed, including experiment design, block
design, acquisition of clinical and histopathological data, block
construction, slide cutting, staining, image acquisition, image anal-
ysis and management of the whole system. TMA-OM, having mul-
tidimensional features, can provide data necessary not only for
researchers but also for technicians, block manufacturers, antibody
producing companies and developers of TMA database systems. As
the ﬁrst application based on TMA-OM, a web-based database
management system, Xperanto-TMA (available at http://xperan-
to.snubi.org/tma/) was implemented.
The TMA-OM supportive database has been suffered from the
complexity of data models, long list of required elements, and
low level of user-friendliness for the non-informatician patholo-
gists. Instead of improving the user interface, we concluded that
we needed a simpler, ease-to-understand representation of TMA
data reﬂecting the perspective of a typical TMA researcher.
To overcome the limitations of TMA-OM, we designed a spread-
sheet-based data exchange format for TMA data. There were three
rationales for the development of a spreadsheet-based format.
First, we tried to address the drawbacks of the TMA DES, which
does not provide detailed instructions for clinical and histopathol-
ogical data, with data structure of each document being dependent
on the author, which creates the possibility that results of identical
experiments might have different data structures. Moreover, be-
cause TMA DES is based on XML, it is not available to most
researchers working in laboratories without bioinformatics sup-
port. Second, the multidimensional nature of TMA-OM is not suit-
able as a data exchange format and needs to be simpliﬁed for TMA
data exchange. We created a new model for TMA data exchange by
selecting and reorganizing the data elements in TMA-OM. The data
exchange format based on this model should provide sufﬁcient
clinical and histopathological information to the level of granular-
ity required for most TMA research. Third, spreadsheets are a use-
ful data exchange format in biomedical research when
experimental design is regular or simple. From our experience,
most TMA research projects have a simple experimental design
and a set of designs can be deﬁned that encompass most projects.
Moreover, spreadsheets are a very familiar format to most
researchers and much TMA data is already stored in this format.
This is not unique to TMAs. Spreadsheet-based data exchange for-mats including MAGE-TAB, PRIDE Proteomics Harvest Spreadsheet,
and ISA-TAB, were developed for cDNAmicroarray, proteomics and
combinations of omics-based experiments, respectively [11–13].
The spreadsheet format has also been used for partial uploading
of TMA data in other TMA database systems [14,15]. The usefulness
of a general format compared to a speciﬁc interface is that it gives
more freedom to both researchers and developers without being
limited to speciﬁc platforms.
In this article we propose TMA-TAB as a spreadsheet-based data
exchange format for TMA data. TMA-TAB can be used for data col-
lection, presentation, and communication between researchers or
machines. It is easy-to-learn without any knowledge about bioin-
formatics. We also implemented an import and export interfaces
to the TMA-OM supported web application, Xperanto-TMA. We ex-
pect that this will accelerate TMA workﬂow, promoting TMA re-
search as a whole.2. Methods
2.1. Conceptual schema
The ﬁrst step in designing a simple and easy-to-learn format for
data exchange was to determine the data elements of TMA exper-
iments that are of concern to researchers. Most researchers are
interested in how results of immunohistochemical assays correlate
with the clinical and histopathological data annotations of each
core section on a slide.
Next, we had to generalize those data elements into several rep-
resentative entities. Experiment, block, slide, core_in_block and
core_in_slide were chosen as ﬁve entities representing essential
TMA data. Core_in_block and core_in_slide play a role in annotat-
ing clinical and histopathological data and interpreting results.
Block and slide connect these two entities and experiment encom-
passes all of these entities. These ﬁve entities were partially imple-
mented by the TMA DES although it did not divide core into
core_in_block and core_in_slide [9]. Using these ﬁve entities, most
of the concepts in TMA data important to researchers can be suc-
cessfully described (Table 2). One of the advantages of introducing
these entities is that these are very familiar concepts to research-
ers, hence enabling easy understanding of the structure and rela-
tionships of the entities.
We then generated attributes for each entity, which explain and
describe the characteristics of each entity. Attributes were drawn
from the classes, attributes and templates of TMA-OM, and these
were reorganized, simpliﬁed and modiﬁed based on the needs of
researchers. This process occurred in four steps. First, only classes
containing real TMA data were selected while classes representing
processes or events were excluded.
Second, the remaining classes were clustered into ﬁve entities
and related classes were combined to produce new attributes if
this process did not cause severe information loss. For example,
the TMA-OM’s TumorInfo class in the HisoPathol package having
Table 2
Overall features of TMA-TAB and its relationship with TMA-OM.
Entities in
TMA-TAB
Data format
in TMA-TAB
Data contents Packages in TMA-OM (percentage of classes
represented by TMA-TAB among total
classes of each package)
Experiment IDF Title, ExpType, ExpFactor, Description, ExternalLink Experiment (100%)
Block BDF BlockIdentiﬁer, NumOfRow, NumOfCol, CoreSize, BlockConstructionProtocol,
BlockCreationDate, Description, ExternalLink
Block (25%), BlockDesign (100%)
Slide SDF SlideIdentiﬁer, SlideStain, SlideTestCategory, SlideSerialNumber, SlideProtocol,
SlideCutDate, SlideStainDate, BlockIdentiﬁer, Description, ExternalLink
Array (67%), BioAssay (9%), Reporter (25%)
Core_in_block CCDF 43 templates dependent on tissue and cancer types DesignElement (33%), BioMaterial (43%),
HistoPathol (100%), ClinInfo (56%)
Core_in_slide CRDF Availability, PercentOfTissueStaining, TissueIntensity, NumberOfNucleiCounted,
EvaluationCategory, StainingCompartment, StainingPattern, CoreType,
InterpretationProtocol, Description, SlideIdentiﬁer, PosRow and PosCol
BioAssayData (6%), QuantitationType (71%)
Absent Protocol
format
ProName, ProType, Description Protocol (10%)
IDF: investigation description format, BDF: block description format, SDF: slide description format, CCDF: core clinicohistopathologic data format, CRDF: core result data
format.
Y.S. Song et al. / Journal of Biomedical Informatics 43 (2010) 435–441 437classes, Tstage, Nstage, Mstage, BasicHistoPathol, NstageInfo, Tsta-
geInfo, MstageInfo, TNMstage, pathologist_reviewed and tumor-
StageCodeType, can be modiﬁed and simpliﬁed as attributes of
Tstage, Mstage, Nstage and pathologists in the core_in_block entity
through uniﬁcation of associated classes. Every class of the TMA-
OM was investigated in this way.
Third, each attribute was evaluated as to whether the data it
represented was really practical in the TMA experiment. As a result
of this process, 53% of classes and 64% of attributes in the TMA-OM
are represented by TMA-TAB. Excluded classes represent an events
or a processes and excluded attributes describe technical details,
most likely beyond the interest of researchers.
Fourth, 43 premade templates in TMA-OM for describing organ-
speciﬁc specimen information were restructured into sets of cate-
gories and values and the categories were added to the attributes
of core_in_block. For example, a template in TMA-OM for gastroin-
testinal lymphoma consists of three common data element (CDE)
groups (Macroscopic, Microscopic, Histologic), 12 categories under
the CDE groups (HistologicType_NonHodgkinLymphoma, Histolog-
icType_B-cellLymphoma, HistologicType_T-cellLymphoma, etc.),
and 75 values under the categories (B-cellLymphoma, T-cellLym-
phoma, Hairy cell leukemia, etc.). The template is restructured by
removing the CDEs, CDE groups, and the hierarchical structures
of the categories and subcategories. The categories, Histologic-
Type_B-cellLymphoma and HistologicType_T-cellLymphoma, for
example, are subcategories of HistologicType_NonHodgkinLym-
phoma. Because hierarchical information is hard to apply to
TMA-TAB and the permissible values for HistologicType_B-cell-
Lymphoma and HistologicType_T-cellLymphoma are mutually
exclusive with each other and exhaustive to the super-category,
HistologicType_NonHodgkinLymphoma, these two subcategories
can be uniﬁed and merged into HistologicType_NonHodgkinLym-
phoma without information loss. Each step involves no informa-
tion loss because the permissible values in the pathologic
diagnosis of a sample for HistologicType_B-cellLymphoma and His-
tologicType_T-cellLymphoma are mutually exclusive and exhaus-
tive to HistologicType_NonHodgkinLymphoma. Then each
restructured category was entered as an attribute into the entity
of core_in_block. The values of each category are used for deter-
mining the permissible values of each cell (see Section 2.3).
After generation of attributes, we deﬁned rules of relationship
between the entities, listed below.
1. An instance of a block is owned by one or more instances of
experiments.
2. An instance of a slide originates from an instance of a block.
3. An instance of a core_in_block is owned by an instance of a block.4. An instance of a core_in_slide originates from an instance of a
core_in_block and also owned by an instance of a slide.
If two entities are related, each entity should have attributes
both for identifying self and for referring to the other entity that
it owns or originates from. In this way, entities can refer to each
other. Referring data from an instance of core_in_slide to an in-
stance of core_in_block is a reﬂection of a real world event of
TMA data processing where researchers analyzing a core in a
TMA slide ﬁnd the corresponding clinical and histopathologic data
annotated to a core with the same coordinates in the source block.
2.2. Formalization of TMA-TAB from conceptual schema
We created ﬁve tab-delimited ﬁles from the premade concep-
tual schema that preserved their structure. These are investigation
description format (IDF) from the experiment in the conceptual
schema, block description format (BDF) from the block, slide
description format (SDF) from the slide, core clinicohistopathologic
data format (CCDF) from the core_in_block and core result data for-
mat (CRDF) from the core_in_slide (Table 2).
Headers in the ﬁrst row correspond to the attributes in the con-
ceptual schema. TMA data is inserted into the cells under the head-
ers. Each row of data corresponds to one instance of an entity.
In the case of CCDF, it was not reasonable to use all the attri-
butes taken from the conceptual schema because important clini-
cal and histopathologic data vary depending on the tissue
examined and the type of cancer. We created, therefore, 43 types
of CCDF templates for 43 cancers according to the College of Amer-
ican Pathologists (CAP) Cancer Protocols and checklists so that
researchers can select a template best describing the experiment.
Besides these ﬁve formats, attributes describing protocols or
procedures in conceptual schema were organized separately into
protocol formats. These are block construction protocol, slide pro-
tocol, pretreatment protocol for antibody or probe, ﬁxation proto-
col, surgical procedures, and slide reading protocol. Though the
same information can be provided regardless of whether data
about protocols or procedures are stored independently (protocol
formats) or in association with IDF, BDF, SDF, CCDF or CRDF, this
reduces the potential redundancy of TMA-TAB.
2.3. Ontology
Vocabularies used in TMA-TAB are taken from MGED Ontology,
TMA DES, terms fromMISFISHIE, CDEs of CAP Cancer Protocols and
NCI CDEs [9,16,17] as in TMA-OM [10]. Permissible values of each
cell were determined by the header and are speciﬁed in the docu-
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selected to be made both convenient to use and compatible with
that of implemented TMA-OM. If the header corresponded to a cat-
egory of a template in TMA-OM, the values under the category in
the template were used for the permissible values of the cell under
the header, slightly modiﬁed for convenience if necessary.2.4. Application
Finally we implemented TMA-TAB on Xperanto-TMA, a web-
based TMA database application using TMA-OM, allowing
researchers to submit TMA data by simply uploading TMA-TAB
ﬁles.3. Results
3.1. Structure of TMA-TAB
TMA-TAB consists of ﬁve tab-delimited ﬁles (IDF, BDF, SDF,
CCDF and CRDF) and additional protocol ﬁles (Table 2). According
to deﬁnitions from the RSBI working group, ‘investigation’ is a
self-contained unit of scientiﬁc inquiry with a holistic hypothesis
or objective and ‘assay’ is a part using particular technologiesFig. 1. Example of TMA-TAB usage w[19]. TMA-TAB can contain data on only one investigation, but
more than one assay can be included under one investigation.
Each ﬁle in TMA-TAB has headers in the ﬁrst row and TMA data
can be inserted starting from the second row (Fig. 1). For the sub-
mission of TMA-TAB into a TMA database, the relationship with
preexisting data should be considered. For example in Xperanto-
TMA, if the value of the ‘Title’ column in IDF is ‘MTA-1 expression
in colon cancer’ and another experiment with the same title has
been already registered in the database, users are prevented from
submitting the TMA data under the same title. Users should check
if the data to be submitted is already stored in the TMA system. If
the ﬁles represent a different experiment the Title attribute should
be changed. With this policy, each experiment in TMA database
system has a unique title, preserving data integrity.
The following is a brief description of each format. For more de-
tailed information and examples of TMA-TAB, please refer to the
document of speciﬁcations (Suppl_TMA_TAB_Speciﬁcation.htm,
Suppl_example_colorectal.xls and Suppl_UML.htm, available at
http://xperanto.snubi.org/TMA/suppl/).
3.1.1. Investigation description format (IDF)
IDF describes the overall outline of an experiment including
experimental factor, design and type. Because TMA-TAB can in-
clude only one instance of a TMA experiment, IDF has only twoith an ovarian cancer template.
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headers are Title, ExpType, ExpFactor, Description, and External-
Link. No additional headers are permitted. Controlled vocabularies
and ontologies including the MGED Ontology, TMA DES, terms
from MISFISHIE, CDEs of CAP Cancer Protocols and NCI CDEs are
applied for the values of ExpType and ExpFactor. Any string can
be applied to describe the Title, Description and ExternalLink, ex-
cept that the values of Title should be unique among the experi-
ments stored in a system for the purpose of eliminating conﬂicts.
All permissible values for each cell in the TMA-TAB format are de-
scribed in the speciﬁcation ﬁle (http://xperanto.snubi.org/tma/
Suppl/Suppl_TMA_TAB_Speciﬁcation.htm).
3.1.2. Block description format (BDF)
BDF contains overall information about blocks such as name,
numbers of rows and columns, and core size. For the submission
of TMA-TAB to TMA database system, the value of BlockIdentiﬁer
should be unique: and data with a block identiﬁer that exists in
the database cannot be resubmitted. Unlike TMA-OM, the unit of
CoreSize is already determined as mm.
3.1.3. Slide description format (SDF)
SDF describes the general information of each slide, such as
slide name, stain and slide test category. For the submission of
TMA-TAB, SlideIdentiﬁer should be unique under a single experi-
ment. This means if slides belong to different experiments, the
same SlideIdentiﬁer is allowed. The value of SlideStain is the name
of the antibody, probe or lectin. For submission, the staining mate-
rial should be registered ﬁrst, providing information about the tar-
get molecule, type of staining, staining compartment and reporter
provider. BlockIdentiﬁer of SDF refers to the name of the block the
slide originates from: information on the block may already exist
in the database or be submitted at the same time.
3.1.4. Core clinicohistopathologic data format (CCDF)
CCDF contains information on tissue cores and annotated clini-
cal and histopathological information. Unlike other formats, CCDF
has 43 templates depending on the tissue and type of cancer and
user-deﬁned data elements can be added to any existing templates.
For example, a template for colorectal cancer has 38 headers,
including BlockIdentiﬁer, PosRow, PosCol, SpecimenId, Fixation,
FixationProtocol, Sex, Age, Histology, HistologicGrade and Tumor-
Size. Although there is no single column for the identiﬁer of the
core, the combination of BlockIdentiﬁer, PosRow (position of
row), and PosCol (position of column) fulﬁlls this role. The unit
of TumorSize is designated as cm.
When describing microscopic conﬁguration of a tumor, ‘inﬁl-
trating’ and ‘invasive’ can refer to similar characteristics, but in
TMA-TAB, ‘inﬁltrating’ is a permissible value while ‘invasive’ is
not permissible in the MicroscopicConﬁguration data element. ThisTable 3
An example of a part of a CCDF for colorectal cancer.
BlockIdentiﬁer PosRow PosCol SpecimenId Sex Age DiagnosisDate Operation
Colon_Array73 1 1 S1991–155 F 41 1991–01-09 Abdomin
Colon_Arrray73 1 2 S1991–325 M 72 1991–01-16 Abdomin
Colon_Arrray73 1 3 S1991–808 M 53 1991–02-06 Abdomin
Colon_Arrray73 2 1 S1991–1000 M 51 1991–02-09 Sigmoide
Colon_Arrray73 2 2 S1991–1131 M 67 1991–02-19 Sigmoide
Colon_Arrray73 2 3 S1991–9999 M 58 1991–02-20 Abdomin
Colon_Arrray74 1 1 S1991–559 F 41 1991–02-22 Abdomin
Colon_Arrray74 1 2 S1991–1225 M 72 1991–03-03 Left hemi
Colon_Arrray74 2 1 S1991–2808 M 53 1991–03-03 Abdomin
Colon_Arrray74 2 2 S1991–1011 M 51 1991–03-05 Left hemi
a If multiple values are allowed in a cell, use ‘|’ as a delimiter. To ﬁnd the ﬁelds where m
(http://xperanto.snubi.org/TMA/suppl/Suppl_TMA_TAB_Speciﬁcation.htm).allows clear description of TMA data that both humans and ma-
chines can understand. Table 3 shows an example of a CCDF of
colorectal cancer (Due to the limitation of space, only part of the
CCDF is shown. An example with the entire CCDF is provided in
the Supplementary material) [18].3.1.5. Core result data format (CRDF)
CRDF contains experimental data on the cores of TMA slides.
Headers include Availability, PercentOfTissueStaining, TissueInten-
sity, NumberOfNucleiCounted, EvaluationCategory, StainingCom-
partment, StainingPattern, CoreType, InterpretationProtocol,
Description, SlideIdentiﬁer, PoswRow and PosCol. The combination
of SlideIdentiﬁer, PosRow, and PosCol serve as a unique identiﬁer.3.2. Implementation of TMA-OM and TMA-TAB as Xperanto-TMA
Xperanto-TMA is a web-based application using MySQL 4.1 and
based on TMA-OM [20]. The relational schema is derived from
TMA-OM by object-relational mapping. The experiment-friendly
interface of Xperanto-TMA was designed with the general work-
ﬂow of a TMA experiment in mind. Xperanto-TMA accommodates
a controlled vocabulary and a template-driven data management
system providing design and registry functionalities. Since Xperan-
to-TMA was implemented in 2006, several functions have been
added to the initial system: the complete list of features is de-
scribed below.3.2.1. Data submission
The data submission function aims to provide an accurate
recording tool by adopting aspects of structured data entry such
as controlled vocabularies and pre-deﬁned data elements. Xperan-
to-TMA provides two ways of data submission: (1) editing online
submission forms for experiment, slide, block and core data and
(2) uploading TMA-TAB ﬁles.
When submitting data by editing online submission forms,
users should enter information about experiment, block and slide
before the submission of data on core_in_block or core_in_slide.
Users can insert TMA data either by typing or by choosing one of
items from the selection box to use the controlled vocabulary.
If users submit data by uploading TMA-TAB, they can select
from ﬁve scenarios. These scenarios are developed for the user’s
convenience for situations when the whole set of experiments is
not completed and only part of the data is available but users want
to upload the data that they have. For example, when TMA blocks
and annotated clinical and histopathologic data have been pre-
pared but the slides have not been stained yet, users can upload
BDF and CCDF by selecting the ﬁfth scenario. After uploading, the
system automatically validates formats, data relevance, and rela-
tionship between each format, preventing incorrect or discrepantName Histology TumorSite TumorSize
operineal resection Adenocarcinoma|Mucinousa Rectum 8
operineal resection Adenocarcinoma Rectum 10
operineal resection Adenocarcinoma Rectum 4
ctomy Adenocarcinoma Sigmoid colon 3.5
ctomy Adenocarcinoma Sigmoid colon 3
operineal resection Adenocarcinoma Rectum 5
operineal resection Adenocarcinoma Rectum 9
colectomy Adenocarcinoma Descending colon 9
operineal resection Adenocarcinoma Rectum 10
colectomy Adenocarcinoma Descending colon 2
ultiple values, refer to the document of speciﬁcation in the Supplementary material
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of TMA-TAB, one can also describe user-deﬁned terms.
3.2.2. Data export: text and XML
Users can export the data for each experiment as well as tissue
information into tab-delimited text and XML ﬁles conforming to
the TMA DES. The exported ﬁle contains all information about
the experiment including array, clinical and histopathological
information.
3.2.3. Controlled vocabulary
Xperanto-TMA utilizes controlled vocabularies including MGED
Ontology [17], 80 tags of TMA DES, terms from MISFISHIE for TMA
experiment procedures, and CDEs extracted from CAP Cancer Pro-
tocols and NCI CDEs for clinical and histopathologic information.
CDEs for clinical and histopathologic information are under the
control of a system administrator but user-deﬁned CDEs can be
added with sysadmin approval. Allowing user-deﬁned CDEs may
eventually require a central ‘standard’ repository of CDEs that are
widely accepted by the TMA data management community. In
the mean time, collaborators can run regional CDE repositories
with administrative control and communicate periodically.
3.2.4. Template management
The template is a form composed of common data elements
(CDEs) which are metadata to describe data. Researchers can use
pre-deﬁned templates provided in Xperanto-TMA but also submit
new templates by organizing CDEs. Xperanto-TMA provides 43
templates based on CAP cancer protocol to guide entries for each
cancer type, and accommodates an ISO 11179-supported data reg-
istry for detailed description of data elements. These functions for
templates and controlled vocabularies allow users to systemati-
cally submit and manage data.
4. Discussion
As mentioned above, TMA-TAB was developed and imple-
mented with tight relationships with TMA-OM to provide a strong
infrastructure for powerful and user-friendly TMA data manage-
ment. We addressed several issues related to these objectives.
4.1. Design and implementation of TMA-TAB
We selected spreadsheets as a basic format of TMA-TAB because
the table structure of spreadsheets is suitable to TMA data and easy
to manage. Though the spreadsheet is a useful format for research-
ers, if there is no way to validate the data, this can become a seri-
ous problem [21]. Xperanto-TMA provides data validation on
submission of TMA-TAB. Data validation is achieved in three ways:
format validation, cell value validation and validation of logical
relationships among formats. In format validation, the application
automatically checks for inconsistencies with IDF, BDF, SDF, CCDF,
CRDF or protocol formats. Each cell is checked for permissible val-
ues in cell value validation. This allows the TMA database system
to adhere to controlled vocabularies. When validating the logical
relationship between formats, for example, if a row in CCDF has
a BlockIdentiﬁer that does not exist, the relationship between
CCDF and BDF is logically wrong. This kind of error can happen
when users insert the wrong identiﬁer value, in which case Xpe-
ranto-TMA can detect and notify the user of the logically incorrect
relationship.
We did not provide detailed information about slide-staining
material, which seems to be a rather technical issue, to focus our
attention on the essential entities such as experiment, block, slide,
core_in_block and core_in_slide, which are more directly related tothe evaluation of experiment. When implementing the interface
for TMA-TAB, this issue can be dealt in various ways according to
user decisions. In Xperanto-TMA, when submitting experiments
utilizing new staining materials, users should complete the forms
about staining materials prior to submitting the TMA-TAB.
4.2. Implications of TMA-TAB and TMA-OM
The use of TMA-TAB is not limited to TMA data submission to a
database system. Because TMA-TAB includes almost all the infor-
mation necessary for the evaluation of an experiment, researchers
can use it to easily understand the entire process of an experiment
and evaluate the data obtained, making it a useful tool for commu-
nication between researchers. It also guides the process of data col-
lection because it informs researchers about generally required
clinical and/or histopathological information and what should be
included when reporting results.
TMA-TAB was developed by an extensive analysis and restruc-
turing of TMA-OM from the perspective of TMA researchers. Data
representation in TMA-TAB may appear less explicit than that of
TMA-OM, however, this can be transformed into a clearly explicit
representation. Such transformation is possible because the nature
of TMA technology and knowledge about clinical medicine and
pathology can provide implicit links between data elements in
TMA-TAB. For example, when the value of a cell in HistologicType
section of TMA-TAB is ‘‘Diffuse large B-cell lymphoma”, the value
should be mapped into category, ‘‘B-cell lymphoma”, even though
it is not explicitly stated in the TMA-TAB that ‘‘Diffuse B-cell lym-
phoma” is a part of ‘‘B-cell lymphoma”. This mapping is supported
by TMA-OM, which provides knowledge about the classiﬁcation of
lymphoma. To present every data element completely explicitly is
almost impractical from a human perspective, especially for do-
main experts, but this step is necessary in data storage. By imple-
menting both TMA-OM and TMA-TAB, we preserve explicit data
semantics while making the process of data exchange more conve-
nient for researchers.
4.3. Features distinguishing Xperanto-TMA from the other public TMA
database systems
There are several major features that distinguish Xperanto-TMA
from the other public TMA database systems recently reported in
the literatures [1,14,15,22,23]. First, Xperanto-TMA can explicitly
represent data elements in the system because it is based on
TMA-OM, an object model which was designed after thorough
investigations of TMA data. It also prevents logically incorrect data
entry. Explicit representation of TMA data also helps development
of other related applications. Second, TMA-OM was developed
through the seamless integration of existing standards in closely
related domains. This means that TMA-OM can grow together with
other standards as the standards are upgraded. Third, the functions
of Xperanto-TMA can be easily extended with other database sys-
tems for ‘‘-omics” technologies. Fourth, through the implementa-
tion of TMA-TAB, Xperanto-TMA can upload data of a TMA
experiment data as a spreadsheet format. Though spreadsheets
have been used in Cruella [14] and Stanford Tissue Microarray
Database [15] to describe results of an experiment, TMA-TAB con-
tains the full range of information of an experiment including
block, slide, clinical and histopathological information as well as
results of interpretation.
4.4. Evaluation study for TMA-TAB
We performed a very brief survey to evaluate TMA-TAB with
ﬁve pathologists, who had experience with TMA experiments but
did not have any bioinformatics knowledge. All of them used MS
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mainly because they had no concept of an informatics applications
based on database management system. We asked the pathologists
to ﬁll in two of each of the MS Excel documents in TMA-TAB format
from two TMA datasets. Given basic instructions on TMA-TAB and
the speciﬁcation with an example TMA-TAB ﬁle, all of them had no
difﬁculty in producing documents in TMA-TAB format with very
high percentage of correctness. After using TMA-TAB, all of them
completed a questionnaire (see supplement) about its practicality
and user-friendliness. Most of them said that the structure of
TMA-TAB appeared to be optimal for the description of TMA data,
time to complete a document describing a TMA experiment would
be shortened, and they would readily use TMA-TAB if a TMA-TAB
‘editor’ were provided. Four of them answered that TMA-TAB is
user-friendly, but one answered that it was not user-friendly with-
out an editor.
4.5. Necessities for the management of user-deﬁned terms in TMA-TAB
and Xperanto-TMA
Although the CAP cancer protocols provide a standard format
for reporting cancer specimens in the practice of surgical pathol-
ogy, they do not always reﬂect the interests of researchers in clin-
ical and histopathologic ﬁndings. For example, no structured
format is provided in current CAP cancer protocols to describe
radiologic ﬁndings of brain tumor. Many studies of brain tumor
have investigated the correlation between histopathological and
radiologic ﬁndings. To describe such data elements not deﬁned in
CAP cancer protocols, user-deﬁned data elements are allowed in
TMA-TAB, initially limited to the user group, he or she belongs
to. If used frequently, we will update vocabulary lists to speciﬁcally
describe these data elements and the templates of TMA-TAB will
be updated accordingly.
4.6. Future works on TMA-TAB
We expect the user-friendliness of TMA-TAB would be en-
hanced by providing a TMA-TAB speciﬁc editor. This would be de-
signed to easily produce a TMA-TAB ﬁle conforming to all the
requirements described in the speciﬁcation of TMA-TAB. Using this
editor would shorten the time required to produce a TMA-TAB ﬁle.
We also have plans for extracting pathology report data in TMA-
TAB format from the electrical medical record. This would require
extensive text mining techniques due to the fact that many pathol-
ogist still provide reports in an unstructured format.
5. Conclusions
We presented both machine-oriented and human-oriented TMA
data representations as TMA-OM and TMA-TAB, respectively, and
demonstrated that these can be used interchangeably. TMA-TAB
may facilitate the process of data submission to TMA-OM support-
ive database systems. Xperanto-TMA, a web-based application on
which TMA-OM and TMA-TAB were completely implemented, is
a robust, easily adaptable database system with strong ability of
data management. These achievements were possible because
the TMA-TAB is based on a thorough analysis of TMA workﬂow.
The development of TMA-TAB, which is essentially a simpliﬁed
transformation of TMA-OM, was rather easier because all of the
up-front work has been completed. This example shows the bene-
ﬁts of a comprehensive data model in the development of othermodels or applications. We will continue to develop easily adapt-
able applications based on the strong infrastructure of TMA-OM
and TMA-TAB.
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